HAE:NYSE
Haemonetics Corp
$118.73
arrow_upward
+0.38%(+0.45) 1D
$120.10
arrow_upward
+1.15% (+1.37)bedtimeAfter hours
Closed: Oct 19, 4:00:04 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
$118.07
High
$119.82
Low
$117.00
Mkt. cap
5.40B
Avg. vol.
681.19K
Volume
389.27K
P/E ratio
57.91
52-wk high
$123.77
52-wk low
$48.98
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
Open
$118.07
High
$119.82
Low
$117.00
Mkt. cap
5.40B
Avg. vol.
681.19K
Volume
389.27K
P/E ratio
57.91
52-wk high
$123.77
52-wk low
$48.98
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
Investing.com Canada
·
35 minutes ago
Haemonetics receives FDA approval for vascular closure device By Investing.com
Stock Titan
·
52 minutes ago
A study found an artery-sealing device stopped bleeding in under a minute on average. FDA approved it.
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorMedical device
Websitehaemonetics.com